1. Home
  2. ECO vs AMLX Comparison

ECO vs AMLX Comparison

Compare ECO & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okeanis Eco Tankers Corp.

ECO

Okeanis Eco Tankers Corp.

HOLD

Current Price

$54.59

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$17.81

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECO
AMLX
Founded
2018
2014
Country
Greece
United States
Employees
N/A
136
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
ECO
AMLX
Price
$54.59
$17.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$42.00
$21.56
AVG Volume (30 Days)
467.3K
1.7M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
6.12%
N/A
EPS Growth
N/A
65.46
EPS
N/A
N/A
Revenue
N/A
$380,786,000.00
Revenue This Year
$16.07
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.60
N/A
Revenue Growth
N/A
1612.94
52 Week Low
$22.38
$7.48
52 Week High
$58.45
$19.15

Technical Indicators

Market Signals
Indicator
ECO
AMLX
Relative Strength Index (RSI) 56.56 61.15
Support Level $48.27 $12.17
Resistance Level $57.47 $18.88
Average True Range (ATR) 2.28 1.04
MACD 0.29 0.05
Stochastic Oscillator 74.55 62.35

Price Performance

Historical Comparison
ECO
AMLX

About ECO Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: